| 摘要 |
The present invention relates to pharmaceutical compositions and methods suitable for the treatment of intestinal disorders and chronic diseases associated with the presence of abnormal distribution of microflora in the gastrointestinal tract of a mammalian host. Furthermore, the present invention relates to pharmaceutical compositions methods suitable for the treatment intestinal disorders and chronic diseases, including but not limited to bacterial infection, irritable bowel syndrome (IBS) or spastic colon, idiopathic ulcerative colitis, mucous colitis, collagenous colitis, Crohn's disease, inflammatory bowel disease, antibiotic-associated colitis, gastrointestinal cancer, and idiopathic or simple constipation and insulin resistance. Moreover, the present invention relates to kits suitable for the treatment of intestinal disorders and chronic diseases associated with the presence of abnormal or an abnormal distribution of microflora in the gastrointestinal tract of a mammalian host. |
